Skip to main content

Animations

MJFF Publications

5901 - 5910 of 8471 Results
Title
Year
  • Year
  • 2018
  • 2018
  • 2018
  • 2018
  • 2018
  • 2018
  • 2018
  • 2018
  • 2018
  • 2018
  • Summary Details
    RESTRICTED
    Title: 5alpha-reductase inhibitors dampen L-DOPA-induced dyskinesia via normalization of dopamine D1-receptor signaling pathway and D1-D3 receptor interaction
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.nbd.2018.09.018
    Best OA location URL:
    Citation Count: 32
  • Summary Details
    RESTRICTED
    Title: Animal models of neurodegenerative diseases
    Journal Name: Nature Neuroscience
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1038/s41593-018-0236-8
    Citation Count: 374
  • Summary Details
    OPEN
    Title: CSF Aβ1–42 level is associated with cognitive decline in early Parkinson’s disease with rapid eye movement sleep behavior disorder
    Journal Name: Translational Neurodegeneration
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s40035-018-0129-5
    Citation Count: 11
  • Summary Details
    OPEN
    Title: USP 14 inhibition corrects an in vivo model of impaired mitophagy
    Journal Name: EMBO Molecular Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.15252/emmm.201809014
    Citation Count: 90
  • Summary Details
    OPEN
    Title: Feasibility and Safety of Multicenter Tissue and Biofluid Sampling for α-Synuclein in Parkinson’s Disease: The Systemic Synuclein Sampling Study (S4)
    Journal Name: Journal of Parkinson’s Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.3233/jpd-181434
    Citation Count: 22
  • Summary Details
    OPEN
    Title: Ingestion of subthreshold doses of environmental toxins induces ascending Parkinsonism in the rat
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-018-0066-0
    Citation Count: 56
  • Summary Details
    OPEN
    Title: Lewy body pathology in Alzheimer's disease: A clinicopathological prospective study
    Journal Name: Acta Neurologica Scandinavica
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1111/ane.13028
    Citation Count: 42
  • Summary Details
    OPEN
    Title: Quantitative Analysis of the Brain Ubiquitylome in Alzheimer's Disease
    Journal Name: PROTEOMICS
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/pmic.201800108
    Citation Count: 63
  • Summary Details
    OPEN
    Title: Unraveling connectivity changes due to dopaminergic therapy in chronically treated Parkinson’s disease patients
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-018-31988-0
    Citation Count: 21
  • Summary Details
    OPEN
    Title: Discriminative Accuracy of [18F]flortaucipir Positron Emission Tomography for Alzheimer Disease vs Other Neurodegenerative Disorders
    Journal Name: JAMA
    Publisher: American Medical Association (AMA)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1001/jama.2018.12917
    Citation Count: 373
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.